Search Results

319 results found for 'che.red'.

First Nigerian manufacturer obtains WHO prequalification for key malaria prevention drug

News | 21 August 2024
...chemoprevention and intermittent preventive treatment in pregnancy WHO has revised the guidelines for three crucial malaria prevention strategies: seasonal malaria chemoprevention (SMC), perennial malaria chemoprevention (PMC, formerly known as intermittent...

view more
New Unitaid report: World’s leading HIV drug proven to have reduced global CO2 emissions by 26 million tons

News | 15 July 2024
...– A new report released today by Unitaid reveals that the lifesaving HIV treatment dolutegravir (DTG) has unexpectedly contributed to a significant reduction in carbon emissions when compared to the...

view more
New Nets Prevent 13 Million Malaria Cases in Sub-Saharan Africa

News | 17 April 2024
...averted using the Interceptor® G2 nets compared to a standard net ranged from $0.66–$3.56* The reduction in malaria cases and deaths from using the Interceptor® G2 nets, compared to a...

view more
Health Care’s Climate Footprint: Saving Lives without Costing the Earth

News | 09 January 2024
...could be reduced without increasing the cost of production Many of these solutions are well proven. Others are more innovative but nevertheless highly promising. Take the example of green chemistry,...

view more
Global health agency Unitaid announces ambitious goal of introducing several “climate-smart” health products by 2030 in a new climate and health strategy released on COP28 Health Day

News | 03 December 2023
...heat stability, reduced plastic content, or are made with “green chemistry,” a chemical product design approach that reduces or eliminates the use of hazardous byproducts. Shaping markets to create sustainable...

view more
Industry Engagement Forum in Lagos aims to increase health product manufacturing in Africa

News | 06 May 2024
Lagos (Nigéria) – The 2024 Industry Engagement Forum, themed “Unlocking Healthcare Value Chains and Driving Investment through Partnerships: Accelerating Equitable Access to Quality-Assured Sustainable Health Products,” is set to take...

view more
Unitaid makes US$31 million investment in harm reduction efforts to prevent hepatitis C among people who inject drugs and others at high risk

News | 18 April 2023
...treatment services within harm reduction programs and piloting the use of two novel/underused products aimed at reducing risks associated with injecting drugs Frontline AIDS, Médecins du Monde, and PATH will...

view more
Innovation critical to achieving the commitments to reduce deaths from malaria made at Ministerial Meeting this week

News | 07 March 2024
...malaria response faster. I commend the strong political will demonstrated at the Malaria Ministerial Meeting and pledge our continued support to reduce malaria cases and deaths.” With over US$130 million...

view more
New Child-Friendly Formulation of Rifapentine for Short Course Tuberculosis Prevention Treatment Now Available as Unitaid and IMPAACT4TB Launch an Early Market Access Vehicle

News | 11 December 2023
...(H) then can be included with rifapentine to make the regimen fully child-friendly. The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, which pioneered the introduction of shorter, rifapentine-based TB...

view more
Ahead of World TB Day, Unitaid and FIND welcome WHO resources to accelerate access to faster, more accurate tests for drug-resistant tuberculosis

News | 21 March 2024
...adequately scaled up Targeted next-generation sequencing (tNGS) is a World Health Organization (WHO)-recommended diagnostic technology that can identify resistance to multiple TB drugs in a matter of days, compared with...

view more

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.